Advisory Opinion 02-13
Concerning whether a proposed arrangement involving financial assistance by a non-profit foundation, which a pharmaceutical company proposes to establish and fund in order to subsidize cost-sharing amounts incurred by financially needy patients using its drug, would violate the administrative authorities related to the anti-kickback statute.